Kissei Pharmaceutical Co (4547) Stock Statistics & Valuation Metrics

Kissei Pharmaceutical Co has a market cap or net worth of ¥171.35B. The enterprise value is ¥141.20K.

Kissei Pharmaceutical Co has 46,541,985 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kissei Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 1.93%.

The current PE Ratio of Kissei Pharmaceutical Co is 12.7. Kissei Pharmaceutical Co’s PEG ratio is 0.67.

In the last 12 months, Kissei Pharmaceutical Co had revenue of 88.33B and earned 11.96B in profits. Earnings per share was 274.20.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Kissei Pharmaceutical Co pays an annual dividend of ¥65, resulting in a dividend yield of 2.48%

Kissei Pharmaceutical Co upcoming earnings date is Jul 31, 2026, TBA (Confirmed).

Kissei Pharmaceutical Co as a current ratio of 6.45, with Debt / Equity ratio of ―

In the past 12 months, Kissei Pharmaceutical Co has paid 3.63B in taxes.

Kissei Pharmaceutical Co EV to EBITDA ratio is 7.12, with an EV/FCF ratio of 71.58.

Kissei Pharmaceutical Co has ¥61.70B in cash and marketable securities with ¥1.25B in debt, giving a net cash position of ¥59.93B billion.

Gross margin is ―, with operating margin of 6.54%, and net profit margin of 13.54%.

The average price target for Kissei Pharmaceutical Co is ¥4,215.00, which is 11.43% higher than the current price. The consensus rating is Hold